Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$209.01 - $232.56 $4.32 Million - $4.81 Million
20,681 Added 157.23%
33,834 $7.39 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $1.29 Million - $1.49 Million
6,546 Added 99.08%
13,153 $2.99 Million
Q4 2023

Feb 08, 2024

SELL
$197.69 - $227.29 $644,469 - $740,965
-3,260 Reduced 33.04%
6,607 $13.2 Million
Q3 2023

Oct 23, 2023

BUY
$201.05 - $221.7 $113,794 - $125,482
566 Added 6.09%
9,867 $1.98 Million
Q2 2023

Jul 24, 2023

SELL
$211.93 - $241.33 $4.28 Million - $4.87 Million
-20,178 Reduced 68.45%
9,301 $2.24 Million
Q1 2023

May 03, 2023

SELL
$213.32 - $257.83 $10.6 Million - $12.8 Million
-49,459 Reduced 62.66%
29,479 $6.76 Million
Q4 2022

Feb 06, 2023

SELL
$203.72 - $248.97 $553,303 - $676,202
-2,716 Reduced 3.33%
78,938 $18.6 Million
Q3 2022

Dec 01, 2022

SELL
$204.81 - $262.19 $13.6 Million - $17.4 Million
-66,234 Reduced 44.79%
81,654 $16.7 Million
Q3 2022

Oct 26, 2022

SELL
$204.81 - $262.19 $13.6 Million - $17.4 Million
-66,234 Reduced 44.79%
81,654 $16.7 Million
Q2 2022

Dec 01, 2022

SELL
$213.86 - $277.87 $47 Million - $61.1 Million
-219,861 Reduced 59.79%
147,888 $34.7 Million
Q2 2022

Jul 27, 2022

SELL
$213.86 - $277.87 $47 Million - $61.1 Million
-219,861 Reduced 59.79%
147,888 $34.7 Million
Q1 2022

Dec 01, 2022

BUY
$259.82 - $298.18 $8.57 Million - $9.83 Million
32,981 Added 9.85%
367,749 $97 Million
Q1 2022

Apr 26, 2022

BUY
$259.82 - $298.18 $8.57 Million - $9.83 Million
32,981 Added 9.85%
367,749 $97 Million
Q4 2021

Dec 01, 2022

BUY
$271.6 - $314.21 $44.6 Million - $51.6 Million
164,328 Added 96.41%
334,768 $105 Million
Q4 2021

Jan 31, 2022

BUY
$271.6 - $314.21 $44.6 Million - $51.6 Million
164,328 Added 96.41%
334,768 $105 Million
Q3 2021

Dec 01, 2022

BUY
$274.82 - $308.34 $18.3 Million - $20.6 Million
66,746 Added 64.37%
170,440 $48 Million
Q3 2021

Oct 20, 2021

BUY
$274.82 - $308.34 $18.3 Million - $20.6 Million
66,746 Added 64.37%
170,440 $48 Million
Q2 2021

Dec 01, 2022

BUY
$251.87 - $278.14 $2.7 Million - $2.99 Million
10,737 Added 11.55%
103,694 $28.6 Million
Q2 2021

Jul 28, 2021

BUY
$251.87 - $278.14 $2.7 Million - $2.99 Million
10,737 Added 11.55%
103,694 $28.6 Million
Q1 2021

Dec 01, 2022

BUY
$204.88 - $255.03 $2.32 Million - $2.88 Million
11,303 Added 13.84%
92,957 $23.7 Million
Q1 2021

Apr 23, 2021

SELL
$204.88 - $255.03 $1.88 Million - $2.34 Million
-9,159 Reduced 8.97%
92,957 $23.7 Million
Q4 2020

Dec 01, 2022

BUY
$186.91 - $214.42 $3.82 Million - $4.39 Million
20,462 Added 25.06%
102,116 $20.8 Million
Q4 2020

Jan 28, 2021

BUY
$186.91 - $214.42 $3 Million - $3.45 Million
16,077 Added 18.69%
102,116 $20.8 Million
Q3 2020

Jan 19, 2021

SELL
$167.03 - $201.3 $297,146 - $358,112
-1,779 Reduced 2.03%
86,039 $16.2 Million
Q3 2020

Oct 29, 2020

BUY
$167.03 - $201.3 $8.27 Million - $9.96 Million
49,496 Added 129.16%
87,818 $16.5 Million
Q2 2020

Jan 19, 2021

SELL
$113.31 - $182.44 $425,365 - $684,879
-3,754 Reduced 8.92%
38,322 $6.37 Million
Q2 2020

Jul 20, 2020

BUY
$113.31 - $182.44 $577,314 - $929,531
5,095 Added 13.78%
42,076 $6.99 Million
Q1 2020

Jan 19, 2021

SELL
$104.32 - $195.28 $341,648 - $639,542
-3,275 Reduced 8.14%
36,981 $4.67 Million
Q1 2020

Apr 30, 2020

BUY
$104.32 - $195.28 $657,737 - $1.23 Million
6,305 Added 18.57%
40,256 $5.09 Million
Q4 2019

Jan 19, 2021

SELL
$163.48 - $173.61 $302,601 - $321,352
-1,851 Reduced 5.17%
33,951 $5.74 Million
Q4 2019

Feb 06, 2020

BUY
$163.48 - $173.61 $384,178 - $407,983
2,350 Added 7.02%
35,802 $6.06 Million
Q3 2019

Jan 19, 2021

SELL
$159.77 - $178.1 $511,903 - $570,632
-3,204 Reduced 8.74%
33,452 $5.62 Million
Q3 2019

Oct 17, 2019

BUY
$159.77 - $178.1 $706,662 - $787,736
4,423 Added 13.72%
36,656 $6.16 Million
Q2 2019

Jan 19, 2021

SELL
$144.16 - $172.9 $703,789 - $844,097
-4,882 Reduced 13.15%
32,233 $5.57 Million
Q2 2019

Jul 19, 2019

BUY
$144.16 - $172.9 $2.76 Million - $3.31 Million
19,147 Added 106.56%
37,115 $6.42 Million
Q1 2019

Jan 19, 2021

SELL
$123.7 - $156.3 $941,604 - $1.19 Million
-7,612 Reduced 29.76%
17,968 $2.75 Million
Q1 2019

May 02, 2019

BUY
$123.7 - $156.3 $938,635 - $1.19 Million
7,588 Added 42.17%
25,580 $3.91 Million
Q4 2018

Jan 19, 2021

SELL
$120.82 - $174.09 $827,858 - $1.19 Million
-6,852 Reduced 27.58%
17,992 $2.27 Million
Q4 2018

Feb 08, 2019

BUY
$120.82 - $174.09 $736,277 - $1.06 Million
6,094 Added 32.5%
24,844 $3.14 Million
Q3 2018

Jan 19, 2021

SELL
$167.67 - $188.27 $1.04 Million - $1.17 Million
-6,219 Reduced 24.91%
18,750 $3.26 Million
Q3 2018

Oct 25, 2018

SELL
$167.67 - $188.27 $345,903 - $388,401
-2,063 Reduced 7.63%
24,969 $4.34 Million
Q2 2018

Jan 19, 2021

SELL
$160.33 - $189.41 $1.5 Million - $1.78 Million
-9,384 Reduced 25.77%
27,032 $4.85 Million
Q2 2018

Aug 03, 2018

BUY
$160.33 - $189.41 $1.39 Million - $1.64 Million
8,666 Added 31.23%
36,416 $6.54 Million
Q1 2018

Jan 19, 2021

SELL
$161.53 - $178.11 $1.51 Million - $1.66 Million
-9,334 Reduced 25.17%
27,750 $4.49 Million
Q1 2018

May 07, 2018

BUY
$161.53 - $178.11 $3.22 Million - $3.55 Million
19,930 Added 116.18%
37,084 $6 Million
Q4 2017

Jan 19, 2021

SELL
$147.99 - $163.95 $1.28 Million - $1.42 Million
-8,683 Reduced 33.61%
17,154 $2.74 Million
Q4 2017

Jan 25, 2018

BUY
$147.99 - $163.95 $2.55 Million - $2.82 Million
17,228 Added 200.12%
25,837 $4.12 Million
Q3 2017

Jan 19, 2021

SELL
$149.47 - $160.56 $1.15 Million - $1.24 Million
-7,710 Reduced 47.25%
8,609 $1.3 Million
Q3 2017

Oct 17, 2017

BUY
$149.47 - $160.56 $1.36 Million - $1.46 Million
9,082 Added 125.49%
16,319 $2.46 Million
Q2 2017

Jan 19, 2021

SELL
N/A
-7,202 Reduced 49.88%
7,237 $1.12 Million
Q2 2017

Aug 08, 2017

BUY
N/A
484 Added 3.47%
14,439 $2.23 Million
Q1 2017

Jan 19, 2021

BUY
N/A
13,955
13,955 $2 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.